Navigation Links
Schering-Plough Schedules Webcast For Annual Meeting of Shareholders
Date:5/11/2009

KENILWORTH, N.J., May 11 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) will hold its Annual Meeting of Shareholders on Monday, May 18, 2009, in Chicago at 7:30 a.m. (CDT) (8:30 a.m. EDT). On that day, a live Webcast of the meeting will be available to all interested parties via the corporate Web site, www.schering-plough.com.

At the Annual Meeting, Fred Hassan, chairman and CEO, will report to shareholders on the company's performance and progress.

The proposed combination with Merck & Co., Inc., is not on the agenda for the Annual Meeting. However, shareholders of Schering-Plough and of Merck will have an opportunity to vote to approve the proposed combination at Special Meetings of Shareholders, anticipated to be held by each company later this year.

Those wishing to listen live to the Webcast of the Annual Meeting should go to the Investor Relations section of the Schering-Plough corporate Web site, www.schering-plough.com, and click on the "Presentations/Webcasts" link. A replay of the Webcast will be available via the Web site later that day.

Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription, animal health and consumer health care products. Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, N.J., and its Web site is <
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Schering-Plough Schedules Conference Call Webcast for 2009 First Quarter Earnings
2. Schering-Plough to Webcast Presentation at Barclays Capital Global Healthcare Conference
3. Video: Schering-Plough Introduces AFRIN(R) PureSea(TM): A Natural, Gentle Nasal Rinse From the Seas of Northern France
4. Novartis/Schering-Ploughs Drug Will Replace AstraZenecas Symbicort as Decision Resources Clinical Gold Standard by 2012 for the Treatment of Asthma
5. Schering-Plough Announces Collaboration With World Health Organization to Provide Access to Pandemic Influenza Vaccine Technology to Developing Countries
6. Schering-Plough Submits Response to FDA for SAPHRIS(TM) (asenapine) in the Acute Treatment of Both Schizophrenia and Bipolar I Disorder
7. Schering-Plough to Webcast Presentation at 27th Annual J.P. Morgan Healthcare Conference
8. HUYA Bioscience Announces Agreement to Provide Schering-Plough With Drug Development Candidates From China
9. Schering-Plough Declares Quarterly Dividends on Common Shares and 2007 Mandatory Convertible Preferred Stock
10. Schering-Plough Reschedules Time of Conference Call, Webcast for 2008 Second Quarter Earnings to Later Today
11. Schering-Plough Announces Closing of Planned Divestiture of Selected Animal Health Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014 ­ RedBrick Health , ... change technology, today announces that EmblemHealth , the ... wellness company, is now providing the RedBrick Compass health ... program, to all of its members. EmblemHealth is among ...
(Date:1/15/2014)... Rochester, NY (PRWEB) January 15, 2014 The ... cause a major disease. One of these latent viruses is ... is rheumatoid arthritis (RA). Rheumatoid arthritis (RA) is a chronic ... the theory, a study found that RA patients have high ...
(Date:1/15/2014)... TaiGen Biotechnology Company, Limited ("TaiGen") today announced that ... leading Russian pharmaceutical company, to develop and commercialize nemonoxacin ... , Turkey and other ... novel antibiotic for the treatment of bacterial infections including ...
(Date:1/14/2014)... 2014 As pet owners drew up their lists of New ... "Take better care of my furry companion." Nowadays there are pet ... carrying cases to take the little canine or feline darlings along ... to buy some pricey toys at the pet store. But anyone ...
Breaking Biology Technology:EmblemHealth Selects RedBrick Health to Power its Next-Generation Health Engagement and Behavior Change System 2EmblemHealth Selects RedBrick Health to Power its Next-Generation Health Engagement and Behavior Change System 3Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4New Year's Resolution: Give Pets the Gift of Top-Notch Health Care 2
... Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) today announced ... pixantrone for the treatment of relapsed/refractory diffuse large B-cell ... patient enrollment. The trial, referred to as the PIX-R ... pixantrone plus rituximab to a combination of gemcitabine plus ...
... 2011 Recent events in Japan have caused the ... radiation can be a cause for concern – especially ... targets rapidly proliferating cells of the body. Cells of ... tract are two such cell types. Damage to these ...
... HILL, N.C., March 18, 2011 Driving value for customers ... are many touch points between a customer and an organization, ... in order for an organization to succeed in the marketplace. ... consulting firm Best Practices, LLC., noted in this month,s special ...
Cached Biology Technology:Cell Therapeutics Initiates Pixantrone PIX-R Pivotal Trial for Treatment of Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma 2Cell Therapeutics Initiates Pixantrone PIX-R Pivotal Trial for Treatment of Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma 3Cell Therapeutics Initiates Pixantrone PIX-R Pivotal Trial for Treatment of Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma 4Existing Radiation Countermeasures Inadequate! Development of Rx100 Promises Change! 2Existing Radiation Countermeasures Inadequate! Development of Rx100 Promises Change! 3Best Practices, LLC Showcases Its Expertise in Customer Relationship Management 2
(Date:4/17/2014)... such as heart disease, epilepsy and pain, making them ... is still much scientists do not know about the ... into the structure of sodium channels and, specifically, one ... responsible for ,fine-tuning, the activity of the channel. The ... the Journal of Biological Chemistry . , Nerves ...
(Date:4/17/2014)... Cell Press journal Current Biology on April ... sex lives. The Brazilian insects, which represent four distinct ... are the first example of an animal with sex-reversed ... in several different animals, Neotrogla is the ... reversed," says Kazunori Yoshizawa from Hokkaido University in Japan. ...
(Date:4/17/2014)... process whereby the genetic information of DNA is ... which have numerous different functions in living organisms. ... during gene expression, by relating the genetic information ... manufacturing proteins. , By examining the different ... an organism at a given time, researchers can ...
Breaking Biology News(10 mins):Structure of sodium channels different than previously believed 2In sex-reversed cave insects, females have the penises 2Rapid and accurate mRNA detection in plant tissues 2
... 2008 From the sun,s UVA rays to tobacco smoke, ... to cancer. Thanks to our body,s DNA repair mechanisms, however, ... the formation of tumours. Now, according to a new ... of the National Academy of Sciences of the USA ...
... administration will confront an array of threats and challenges ... president, says Steve Fetter, dean of the University of ... Fetter asked six experts on his faculty with deep ... steps to address key challenges. Most of ...
... CAMBRIDGE, Mass. -- MIT engineers have outfitted cells with tiny ... tumors or become building blocks for tissue engineering. Michael ... and senior author of a paper on the work that ... said he believes this is the first time anyone has ...
Cached Biology News:Repairing DNA damage: Researchers discover critical process in cancer treatment 2Advice to the new administration: UM foreign and domestic policy guide 2Advice to the new administration: UM foreign and domestic policy guide 3Advice to the new administration: UM foreign and domestic policy guide 4Advice to the new administration: UM foreign and domestic policy guide 5Advice to the new administration: UM foreign and domestic policy guide 6Advice to the new administration: UM foreign and domestic policy guide 7MIT creates tiny backpacks for cells 2
For relative and/or absolute quantification with standard accuracy requirements using MS or NMR instruments...
Carrier Serum...
A Highly Purified, Cost-Effective Taq DNA Polymerase...
Homo sapiens similar to Cytosolic acyl coenzyme A thioester hydrolase Antigen: Peptide...
Biology Products: